fda glp-1 safety warning september 2025 compounding letters Congress Introduces SAFE Drugs Act of 2025, Expanding Oversight of Compounded Drugs and Telehealth Providers Beyond the Headlines: FDA Warning – FDA unleashes warning letters to

15,20 Serious GI AEs, though uncommon, have also been reported with GLP-1 RA therapy, including gastroparesis, intestinal obstruction, pancreatitis, and colonic ischemia

Boronic acid-based arginase inhibitors in cancer immunotherapy

It seizes any opportunity to spread into new territory, crowding out good bacteria and messing with the immune system

Clinical guidance notes that these foods can delay stomach emptying and relax the lower esophageal sphincter, making reflux more likely.69 For many, starting with these diet and lifestyle shifts and layering in prebiotics or probiotics as needed may make more sense than relying indefinitely on digestive enzyme supplements, especially in the absence of a clearly documented enzyme deficiency